ASSESSMENT ON TELEMEDICINE DURING THE ERA OF COVID-19; PERSPECTIVES AND SATISFACTION ABOUT WHAT CAN SAUDI ARABIA DO IN MAKKAH AL-MUKARRAMAH 2022.
Main Article Content
Keywords
Telemedicine, Satisfaction, COVID-19, Type2 Diabetes, Saudi Arabia in Makka Al-Mukarramah
Abstract
Background: COVID-19 still poses a threat to healthcare (HC). In late 2019, a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was discovered as the source of an outbreak of acute respiratory illness in Wuhan city, China. The World Health Organization announced a public health emergency and described the virus and its associated disease, coronavirus disease 2019 (COVID-19), as a pandemic in March 2020. In Saudi Arabia, the government applied precautionary actions to decrease and limit the spread of the virus by suspending schools, closing offices, and enforcing lockdown which lasted for approximately three months (March 25th, 2020 to June 21st, 2020). Additionally, promotion of social distancing practices and other preventative measures were continued and re-emphasized after the lockdown ended. The coronavirus disease 2019 (COVID-19) pandemic has represented a challenge to medical practice in Saudi Arabia and worldwide. In contrary to the increasing numbers of COVID-19 patients, there was a limitation in the capacity of medical practices and access to healthcare. A growing body of evidence from healthcare settings in Saudi Arabia and worldwide has suggested a possible role for telemedicine in responding to this evolving need. Telemedicine can be used for triage, direct care, follow-up, and consultation. Aim of the study: To Assessment on Telemedicine during the Era of COVID-19; Perspectives and Satisfaction about what Can Saudi Arabia Do in Makkah Al-Mukarramah 2022 .Method: cross sectional study conducted about Implementation of a Telemedicine what Can Saudi Arabia Do during the of COVID-19 among health care, diabetes Type 2 virtual clinic During the Coronavirus Disease Outbreak. Our total participants were (250) patients with Type 2 Diabetes attending a Telemedicine clinic. Results: most of the participants (35.2%) were in the age group 55-64 years, the majority of them were female (72.0%), also regarding Nationality the majority of participant are Saudi were(85.2%), regarding Educational level the majority of participant are University were(38.0%). Regarding the Job the majority of participant Private sector employee were (32.0%). Conclusion: Telemedicine provide encouraging empirical support for the usability and clinical value of a diabetes telehealth program integrating and a clinical decision support tool that was delivered to an T2D clinic population, patients and HCPs make it a suitable model to be adopted by clinics, especially during pandemics or disasters in resource-limited settings.
Downloads
References
1. Bostanciklioğlu, M. (2020). Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. Current neurovascular research, 17(4), 342-343. 2. Perkins, T. A., Cavany, S. M., Moore, S. M., Oidtman, R. J., Lerch, A., & Poterek, M. (2020). Estimating unobserved SARS-CoV-2 infections in the United States. Proceedings of the National Academy of Sciences, 117(36), 22597-22602. 3. World Health Organization. (2020). Coronavirus disease 2019 (COVID-19): situation report, 51. 4. Brown, H. L., & DeNicola, N. (2020). Telehealth in maternity care. Obstetrics and Gynecology Clinics, 47(3), 497-502. 5. Zonneveld, M., Patomella, A. H., Asaba, E., & Guidetti, S. (2020). The use of information and communication technology in healthcare to improve participation in everyday life: a scoping review. Disability and rehabilitation, 42(23), 3416-3423. 6. Al-Sofiani, M. E., Alyusuf, E. Y., Alharthi, S., Alguwaihes, A. M., Al-Khalifah, R., & Alfadda, A. (2021). Rapid implementation of a diabetes telemedicine clinic during the coronavirus disease 2019 outbreak: our protocol, experience, and satisfaction reports in Saudi Arabia. Journal of diabetes science and technology, 15(2), 329-338. 7. Alharthi, S., Alrajeh, A., Alyusuf, E., Alguwaihes, A. M., Jammah, A., & Al-Sofiani, M. E. (2022). “Pre-Ramadan” telemedicine: Effect on fasting experience and glycemic control during ramadan in people with type 1 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(8), 102567. 8. Qureshi, A. Z., Ullah, S., Aldajani, A. A., Basson, P., AlHabter, A. M., Ali, T., ... & Al Jadid, M. S. (2021). Telerehabilitation guidelines in Saudi Arabia. Telemedicine and e-Health, 27(10), 1087-1098. 9. Bansal, P., Bingemann, T. A., Greenhawt, M., Mosnaim, G., Nanda, A., Oppenheimer, J., ... & Shaker, M. (2020). Clinician wellness during the COVID-19 pandemic: extraordinary times and unusual challenges for the allergist/immunologist. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1781-1790. 10. Elbarbary, N. S., Dos Santos, T. J., de Beaufort, C., Wiltshire, E., Pulungan, A., & Scaramuzza, A. E. (2021). The challenges of managing pediatric diabetes and other endocrine disorders during the COVID-19 pandemic: results from an international cross-sectional electronic survey. Frontiers in endocrinology, 1447. 11. Nittari, G., Savva, D., Tomassoni, D., Tayebati, S. K., & Amenta, F. (2022). Telemedicine in the COVID-19 Era: A Narrative Review Based on Current Evidence. International Journal of Environmental Research and Public Health, 19(9), 5101. 12. Al Amro, S. A., Al Ghamdi, S. M., Abouammoh, M. A., Al Aql, F., Ahmad, K., & Alsulaiman, S. M. (2022). Saudi Arabian retinopathy of prematurity national telemedicine program: Achievements and challenges. Saudi Journal of Ophthalmology, 36(3), 278. 13. Al-Khalifa, K. S., & AlSheikh, R. (2020). Teledentistry awareness among dental professionals in Saudi Arabia. PLoS One, 15(10), e0240825. 14. Stavropoulos, K. K. M., Bolourian, Y., & Blacher, J. (2022). A scoping review of telehealth diagnosis of autism spectrum disorder. PloS one, 17(2), e0263062. 15. Ansori, A. N. M., Kharisma, V. D., Fadholly, A., Tacharina, M. R., Antonius, Y., & Parikesit, A. A. (2021). Severe acute respiratory syndrome coronavirus-2 emergence and its treatment with alternative medicines: A review. Research Journal of Pharmacy and Technology, 14(10), 5551-5557. 16. Hsu, W. C., Lau, K. H. K., Huang, R., Ghiloni, S., Le, H., Gilroy, S., ... & Moore, J. (2016). Utilization of a cloud-based diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes technology & therapeutics, 18(2), 59-67. 17. Balquin, J. C., Escuadro, I. M. A., Jacinto, V. C. E., Faller, E. M., & Gania, M. (2022). The Effectiveness of Collaborative Telemedicine among Diabetic Patients in Koronadal City, South Cotabato. GSJ, 10(3). 18. Lee, V. J., Chiew, C. J., & Khong, W. X. (2020). Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. Journal of travel medicine, 27(3), taaa039. 19. Dawood, F. S., Ricks, P., Njie, G. J., Daugherty, M., Davis, W., Fuller, J. A., ... & Bennett, S. D. (2020). Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. The Lancet Infectious Diseases, 20(11), 1255-1262. 20. Alotaibi, A. S., & Boukelia, B. (2021). The effect of pre-quarantine physical activity on anxiety and depressive symptoms during the COVID-19 lockdown in the Kingdom of Saudi Arabia. International journal of environmental research and public health, 18(15), 7771. 21. Aberer, F., Hochfellner, D. A., & Mader, J. K. (2021). Application of telemedicine in diabetes care: The time is now. Diabetes Therapy, 12(3), 629-639. 22. Calikoglu, F., Bagdemir, E., Celik, S., Idiz, C., Ozsarı, H., Issever, H., & Satman, I. (2022). Telemedicine as a Motivational Tool to Optimize Metabolic Control in Patients with Diabetes in Turkey: A Prospective, Randomized, Controlled TeleDiab Trial. Telemedicine and e-Health 23. Yomoda, K., & Kurita, S. (2021). Influence of social distancing during the COVID-19 pandemic on physical activity in children: A scoping review of the literature. Journal of Exercise Science & Fitness, 19(3), 195-203. 24. Altulaihi, B. A., Alharbi, K. G., Alhassan, A. M., Altamimi, A. M., & Al Akeel, M. A. (2021). Physician’s perception toward using telemedicine during COVID-19 pandemic in King Abdulaziz Medical City, Riyadh, Saudi Arabia. Cureus, 13(7). 25. Aldarhami, A., Bazaid, A. S., Althomali, O. W., & Binsaleh, N. K. (2020). Public perceptions and commitment to social distancing “staying-at-home” during COVID-19 pandemic: a national survey in Saudi Arabia. International Journal of General Medicine, 13, 677. 26. Al Argan, R., Alkhafaji, D., Al Elq, A., Albaker, W., Alqatari, S., Alzaki, A., ... & Alabdrabalnabi, F. I. (2021). The Impact of Diabetes Mellitus and Hyperglycemia on the Severity and Outcome of Patients with COVID-19 Disease: A Single-Center Experience. International Journal of General Medicine, 14, 9445. 27. Hernández-Jiménez, S., García-Ulloa, A. C., Alcántara-Garcés, M. T., Urbina-Arronte, L. E., Lara-Sánchez, C., Velázquez-Jurado, H. R., & Group of Study CAIPaDi. (2021). Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic. Therapeutic Advances in Endocrinology and Metabolism, 12, 20420188211059882. 28. Al-Hazmi, A. M., Sheerah, H. A., & Arafa, A. (2021). Perspectives on Telemedicine during the Era of COVID-19; What Can Saudi Arabia Do?. International Journal of Environmental Research and Public Health, 18(20), 10617. 29. El Kheir, D. Y. M., Alnufaili, S. S., Alsaffar, R. M., Assad, M. A., & Alkhalifah, Z. Z. (2022). Physicians’ Perspective of Telemedicine Regulating Guidelines and Ethical Aspects: A Saudi Experience. International Journal of Telemedicine and Applications, 2022. 30. Mubaraki, A. A., Alrabie, A. D., Sibyani, A. K., Aljuaid, R. S., Bajaber, A. S., & Mubaraki, M. A. (2021). Advantages and disadvantages of telemedicine during the COVID-19 pandemic era among physicians in Taif, Saudi Arabia. Saudi medical journal, 42(1), 110. 31. Smith, W. R., Atala, A. J., Terlecki, R. P., Kelly, E. E., & Matthews, C. A. (2020). Implementation guide for rapid integration of an outpatient telemedicine program during the COVID-19 pandemic. Journal of the American College of Surgeons, 231(2), 216-222. 32. Jannati, N., Nakhaee, N., Yazdi-Feyzabadi, V., & Tjondronegoro, D. (2021). A cross-sectional online survey on patients’ satisfaction using store-and-forward voice and text messaging teleconsultation service during the covid 19 pandemic. International Journal of Medical Informatics, 151, 104474. 33. Rohilla, L., Dayal, D., Malhi, P., Bharti, B., Kaur, S., & Dhandapani, M. (2021). Development and evaluation of a culturally tailored education module for type 1 diabetes in a resource-constrained setting: protocol for a mixed-methods study. International Journal, 8(3), 244. 34. Khalil, A., Hill, R., Ladhani, S., Pattisson, K., & O'Brien, P. (2021). COVID-19 screening of health-care workers in a London maternity hospital. The Lancet Infectious diseases, 21(1), 23-24. 35. Khan, A., Alahmari, A., Almuzaini, Y., Alturki, N., Aburas, A., Alamri, F. A., ... & Jokhdar, H. A. (2021). The role of digital technology in responding to COVID-19 pandemic: Saudi Arabia’s experience. Risk Management and Healthcare Policy, 14, 3923. 36. Cui, F., Ma, Q., He, X., Zhai, Y., Zhao, J., Chen, B., ... & Wang, Z. (2020). Implementation and application of telemedicine in China: cross-sectional study. JMIR mHealth and uHealth, 8(10), e18426. 37. Cassar, M. R., Borg, D., Camilleri, L., Schembri, A., Anastasi, E. A., Buhagiar, K., ... & Grech, M. (2021). A novel use of telemedicine during the COVID-19 pandemic. International Journal of Infectious Diseases, 103, 182-187.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.